PARIS, France—After TAVR, patients prescribed single antiplatelet therapy are less likely to report a major adverse event at 3 months than those on dual antiplatelet therapy, according to results of ...
Dental extraction is performed frequently and can be accompanied by perioperative or postoperative complications. Bleeding is among the most common and important issues to consider in the ...
WASHINGTON, DC—Compared with dual antiplatelet therapy (DAPT), taking a single antiplatelet following TAVI is associated with a lower rate of all-cause mortality and major bleeding at 6 months, ...
Antiplatelet drug therapy has become one of the cornerstones of treatment for patients with cardiovascular disease. Large clinical trials have shown that antiplatelet medications have important ...
Please provide your email address to receive an email when new articles are posted on . Single antiplatelet therapy was tied to lower 6-month mortality risk vs. dual antiplatelet therapy after ...
Dual antiplatelet therapy after heart bypass surgery is not more effective than aspirin alone - and it increases the risk of excessive bleeding. This has now been shown in a study of 2,201 patients at ...
Antiplatelet therapy is a key component in the management of many medical diseases to decrease the risk of cardiovascular events.1 Acetylsalicyclic acid (ASA) is the most common antiplatelet agent ...
Treatment guidelines say patients who undergo minimally invasive aortic heart valve replacements should receive two antiplatelet drugs to reduce the risk of dangerous blood clots. A new study has ...
Current guidelines recommend dual antiplatelet therapy, a combination of aspirin and a P2Y 12 inhibitor, for 6–12 months after percutaneous coronary intervention with drug-eluting stent implantation ...
Please provide your email address to receive an email when new articles are posted on . The efficacy of dual antiplatelet therapy vs. aspirin in patients with stroke was similar when given less than ...
DUBLIN--(BUSINESS WIRE)--The "Antiplatelet Market: Analysis By Drug Class, By Route of Administration, By Distribution Channel, By Region Size and Trends" report has been added to ...